Samuel Rahbar
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Advanced Glycation End Products research 14
-
- Natural Antidiabetic Agents Studies 10
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Co-authors
- James L. Figarola (12 shared papers)Helen M. Ranney (2 shared papers)Olga O. Blumenfeld (1 shared paper)Noe Gonzales (4 shared papers)Rama Natarajan (2 shared papers)Jerry L. Nadler (2 shared papers)Stephen Scott (2 shared papers)Stephen H. Scott (2 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (3 papers)Clinica Chimica Acta (3 papers)Biochemical Pharmacology (2 papers)Annals of the New York Academy of Sciences (2 papers)Cancer Research (1 paper)
- Partner nations
- United StatesIranItaly
In The Last Decade
Samuel Rahbar
31 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 115
- Clinical Biochemistry 790
- Endocrinology, Diabetes and Metabolism 785
- Biochemistry 138
- Physiology 338
- Genetics 137
Countries citing papers authored by Samuel Rahbar
This map shows the geographic impact of Samuel Rahbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Rahbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Rahbar more than expected).
Fields of papers citing papers by Samuel Rahbar
This network shows the impact of papers produced by Samuel Rahbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Rahbar. The network helps show where Samuel Rahbar may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel Rahbar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 285 | |
| 2 | 1968 | 277 | |
| 3 | 1969 | 276 | |
| 4 | 2000 | 128 | |
| 5 | 2000 | 98 | |
| 6 | 2005 | 89 | |
| 7 | 2007 | 64 | |
| 8 | 2007 | 62 | |
| 9 | 2014 | 57 | |
| 10 | 2008 | 57 | |
| 11 | 1999 | 44 | |
| 12 | 1973 | 40 | |
| 13 | 2013 | 38 | |
| 14 | 1986 | 30 | |
| 15 | 2013 | 27 | |
| 16 | 2011 | 25 | |
| 17 | 2012 | 20 | |
| 18 | 1984 | 20 | |
| 19 | 2005 | 18 | |
| 20 | 1999 | 18 |
About Samuel Rahbar
Samuel Rahbar is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Genetics, Physiology and Molecular Biology, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (14 papers), Natural Antidiabetic Agents Studies (10 papers), Hemoglobinopathies and Related Disorders (9 papers), Hemoglobin structure and function (6 papers), Erythrocyte Function and Pathophysiology (6 papers), Alcohol Consumption and Health Effects (5 papers), Neonatal Health and Biochemistry (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Clinical Biochemistry (790 citations), Endocrinology, Diabetes and Metabolism (785 citations), Biochemistry (138 citations), Physiology (338 citations) and Genetics (137 citations). Samuel Rahbar has collaborated with scholars based in United States, Iran and Italy. Frequent co-authors include James L. Figarola, Helen M. Ranney, Olga O. Blumenfeld, Noe Gonzales, Rama Natarajan, Jerry L. Nadler, Stephen Scott, Stephen H. Scott, Sanjay Awasthi and Sharad S. Singhal. Their work appears in journals such as Biochemical and Biophysical Research Communications, Clinica Chimica Acta, Biochemical Pharmacology, Annals of the New York Academy of Sciences and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.